Skye Pharma Inc - San Diego, California 92121

Skye Pharma Inc is categorized under Wholesale Pharmaceutical Products in San Diego, CA .

Business Name: Skye Pharma Inc
Contact Person: Steve Thornton
Address: 10450 Science Center Drive, San Diego, California 92121
Phone Number: (858) 625-2424
Website Address: pacira.com
Annual Revenue (USD): $100.000 to $499.999
Founding Year: 2010
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Wholesale Pharmaceutical Products
SIC Code: 5122
NAICS Code: 424210
Share This Business:
Related Businesses: Dithera Inc - San Diego, CA 92121
Priority Pharmaceuticals - San Diego, CA 92121
Southern California Compounding Pharmacy - San Diego, CA 92121
Therinject - San Diego, CA 92121
Priority Pharmaceuticals Inc - San Diego, CA 92121
Signal Pharmaceuticals LLC - San Diego, CA 92121
Polynoma - San Diego, CA 92121
Cardinal Health - San Diego, CA 92121
Sundia Meditech Inc - San Diego, CA 92121
Salameh Tamer - San Diego, CA 92121
Celgene Corporation - San Diego, CA 92121
Fgx Pharmaceuticals - San Diego, CA 92121
Irisys Inc - San Diego, CA 92121
Epicyte Pharmaceuticals Inc - San Diego, CA 92121
Omnicare of San Diego - San Diego, CA 92121
Zensung USA Inc - San Diego, CA 92121

The company Skye Pharma Inc provides B2B services in the form of Wholesale Pharmaceutical Products from its single location in California. 1 to 4 employees work for Skye Pharma Inc, and the business now earns $100.000 to $499.999 per annum.

Skye Pharma Inc was launched in 2010 and is classified under SIC code and category 5122 , and NAICS number and grouping 424210 . To contact Skye Pharma Inc, please call Steve Thornton with the phone number (858) 625-2424 or visit its single location at 10450 Science Center Drive in San Diego, California 92121.

The location of the single location can also be found using the coordinates 32.891843,-117.231534. Read more details about this business on the webpage pacira.com or follow the company’s social media accounts, on Twitter and on Facebook.